The Promising Future of Long-term Peritoneal Dialysis

Overview

Journal Int Urol Nephrol

Publisher Springer

Specialty Nephrology

Date 2008 Mar 28

PMID 18368504

Citations 8

Authors

Dimitrios Oreopoulos

Elias Thodis

Kosmas I Paraskevas

Affiliations

Soon will be listed here.

Citing Articles

Safety and efficacy of angiotensin receptor neprilysin inhibitor in improving cardiac function and blood pressure in dialysis patients.

Zhou K, Zhang Q, Dong W, Li X, Sun Y, Zhang Y Front Med (Lausanne). 2024; 11:1421085.

PMID: 39301489 PMC: 11410709. DOI: 10.3389/fmed.2024.1421085.

APD or CAPD: one glove does not fit all.

Roumeliotis A, Roumeliotis S, Leivaditis K, Salmas M, Eleftheriadis T, Liakopoulos V Int Urol Nephrol. 2020; 53(6):1149-1160.

PMID: 33051854 PMC: 7553382. DOI: 10.1007/s11255-020-02678-6.

Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.

Dousdampanis P, Trigka K, Chu M, Khan S, Venturoli D, Oreopoulos D Int Urol Nephrol. 2010; 43(1):203-9.

PMID: 20953705 DOI: 10.1007/s11255-010-9716-9.

Cardiovascular events in chronic dialysis patients: emphasizing the importance of vascular disease prevention.

Paraskevas K, Kotsikoris I, Koupidis S, Tzovaras A, Mikhailidis D Int Urol Nephrol. 2010; 42(4):999-1006.

PMID: 20574691 DOI: 10.1007/s11255-010-9795-7.

Glomerular filtration rate (GFR) estimated from serum creatinine predicts total (urine and peritoneal) creatinine clearance in patients on peritoneal dialysis.

Taskapan H, Theodoros P, Tam P, Bargman J, Oreopoulos D Int Urol Nephrol. 2010; 42(4):1085-92.

PMID: 20364322 DOI: 10.1007/s11255-010-9715-x.

References

Zelenitsky S, Barns L, Findlay I, Alfa M, Ariano R, Fine A . Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998. Am J Kidney Dis. 2000; 36(5):1009-13. DOI: 10.1053/ajkd.2000.19103. View

Numata M, Nakayama M, Nimura S, Kawakami M, Lindholm B, Kawaguchi Y . Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate. Perit Dial Int. 2003; 23(2):116-22. View

Linden T, Forsback G, Deppisch R, Henle T, Wieslander A . 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis. Perit Dial Int. 1998; 18(3):290-3. View

Quinn R, Oliver M . Is assisted peritoneal dialysis an alternative to in-center hemodialysis?. Perit Dial Int. 2006; 26(6):650-3. View

Ahmad S, Sehmi J, Ahmad-Zakhi K, Clemenger M, Levy J, Brown E . Impact of new dialysis solutions on peritonitis rates. Kidney Int Suppl. 2006; (103):S63-6. DOI: 10.1038/sj.ki.5001917. View

Williams J, Topley N, Craig K, Mackenzie R, Pischetsrieder M, Lage C . The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004; 66(1):408-18. DOI: 10.1111/j.1523-1755.2004.00747.x. View

Salonen T, Reina T, Oksa H, Rissanen P, Pasternack A . Alternative strategies to evaluate the cost-effectiveness of peritoneal dialysis and hemodialysis. Int Urol Nephrol. 2007; 39(1):289-98. DOI: 10.1007/s11255-006-9141-2. View

Thodis E, Passadakis P, Ossareh S, Panagoutsos S, Vargemezis V, Oreopoulos D . Peritoneal catheter exit-site infections: predisposing factors, prevention and treatment. Int J Artif Organs. 2003; 26(8):698-714. DOI: 10.1177/039139880302600802. View

Kuriyama S, Tomonari H . Corticosteroid therapy in encapsulating peritoneal sclerosis. Nephrol Dial Transplant. 2001; 16(6):1304-5. DOI: 10.1093/ndt/16.6.1304. View

10.

Kam-Tao Li P, Chow K, Wong T, Leung C, Szeto C . Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med. 2003; 139(2):105-12. DOI: 10.7326/0003-4819-139-2-200307150-00010. View

11.

Combet S, Miyata T, Moulin P, Pouthier D, Goffin E, Devuyst O . Vascular proliferation and enhanced expression of endothelial nitric oxide synthase in human peritoneum exposed to long-term peritoneal dialysis. J Am Soc Nephrol. 2000; 11(4):717-728. DOI: 10.1681/ASN.V114717. View

12.

Moncrief J, Popovich R, Broadrick L, He Z, SIMMONS E, Tate R . The Moncrief-Popovich catheter. A new peritoneal access technique for patients on peritoneal dialysis. ASAIO J. 1993; 39(1):62-5. View

13.

Davies S, Woodrow G, Donovan K, Plum J, Williams P, Johansson A . Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003; 14(9):2338-44. DOI: 10.1097/01.asn.0000083904.12234.27. View

14.

Lee H, Park H, Seo B, Do J, Yun S, Song H . Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int. 2005; 25(3):248-55. View

15.

Kawanishi H, Harada Y, Sakikubo E, Moriishi M, Nagai T, Tsuchiya S . Surgical treatment for sclerosing encapsulating peritonitis. Adv Perit Dial. 2000; 16:252-6. View

16.

Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V . The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv Perit Dial. 2000; 16:257-61. View

17.

Annigeri R, Conly J, Vas S, Dedier H, Prakashan K, Bargman J . Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int. 2002; 21(6):554-9. View

18.

Montenegro J, Saracho R, Gallardo I, Martinez I, Munoz R, Quintanilla N . Use of pure bicarbonate-buffered peritoneal dialysis fluid reduces the incidence of CAPD peritonitis. Nephrol Dial Transplant. 2007; 22(6):1703-8. DOI: 10.1093/ndt/gfl848. View

19.

Yang X, Fang W, Kothari J, Khandelwal M, Naimark D, Jassal S . Clinical outcomes of elderly patients undergoing chronic peritoneal dialysis: experiences from one center and a review of the literature. Int Urol Nephrol. 2007; 39(4):1295-302. DOI: 10.1007/s11255-007-9279-6. View

20.

. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J Am Soc Nephrol. 1996; 7(11):2403-8. DOI: 10.1681/ASN.V7112403. View